Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICGeneric

OTIPRIO

CIPROFLOXACIN

Standard Dose
6% (60MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OTIPRIO is listed in Drugs@FDA under application 207986 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN Form and strength INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML) Sponsor ALK ABELLO Submission history Latest submission status date: 2018-03-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview OTIPRIO is listed in Drugs@FDA under application 207986 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN Form and strength INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML) Sponsor ALK ABELLO Submission history Latest submission status date: 2018-03-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.